The Maxoratide IGF-1 LR3 Peptide 1mg (Insulin-like Growth Factor-1 Long Arg3) is a highly purified synthetic protein and extended analogue of human IGF-1. This 83-amino acid compound includes a 13-amino acid extension at the N-terminus and a substitution of Arginine for Glutamic Acid at position 3. These precise structural enhancements make it a key subject of investigation in cellular hyperplasia and musculoskeletal research.
At Maxoratide, we adhere strictly to research-grade standards. Each batch of IGF-1 LR3 Peptide 1mg undergoes comprehensive independent testing to confirm structural integrity, ensuring researchers receive high-quality compounds for in-vitro cell culture and tissue regeneration studies.
Mechanism of Action: Reduced Interaction with IGF-Binding Proteins
In standard laboratory models, native IGF-1 exhibits a short half-life (approximately 20 minutes) due to rapid binding and inactivation by Insulin-like Growth Factor Binding Proteins (IGFBPs). The structural modifications in IGF-1 LR3 enable it to minimize this interaction, resulting in a significantly extended half-life—estimated between 20 to 30 hours—and enhanced biological activity in vitro.
Key Research Pathways
- Cellular Hyperplasia: Unlike compounds that only increase cell size (hypertrophy), IGF-1 LR3 is studied for its potential to stimulate cellular hyperplasia—promoting the formation of new cells within musculoskeletal tissue.
- Amino Acid Transport: Research suggests it enhances the uptake of amino acids and glucose into cells, supporting cellular growth, repair, and metabolic activity.
- Anti-Catabolic Effects: Studies indicate it may inhibit protein degradation pathways and reduce cellular apoptosis, making it valuable in research focused on tissue preservation and regeneration.
Why Source from Maxoratide?
- Verified Analytical Quality: Every batch is tested using High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry to ensure ≥99% purity. COA lab results are available for independent verification.
- US-Based Operations: Orders are shipped directly from our climate-controlled facility in Charlotte, NC, minimizing delays and avoiding risks associated with international shipping.
- Strict Handling Standards: All peptides are processed and stored in sterile, controlled environments to preserve molecular integrity prior to delivery.
Advanced Reconstitution & Storage Protocols
Due to its complex 83-amino acid structure, IGF-1 LR3 Peptide 1mg requires careful and precise reconstitution. While bacteriostatic water is suitable for short-term applications, many researchers prefer using a 0.6% acetic acid solution to improve long-term stability and prevent peptide adhesion to the vial. It can then be further diluted with bacteriostatic water as needed.
When adding the diluent, allow it to flow gently along the inner wall of the vial to avoid damaging the peptide chain. Do not shake or agitate the vial. Instead, gently roll it between your fingers until fully dissolved and optically clear. Foaming may indicate structural degradation and should be avoided.
Storage Guidelines:
- Before Reconstitution: Store lyophilized powder at -20°C
- After Reconstitution: Refrigerate at 4°C
- Always avoid repeated freeze-thaw cycles
Researchers should use appropriate personal protective equipment (PPE), such as nitrile gloves, during handling.
Research Disclaimer
Maxoratide IGF-1 LR3 Peptide 1mg is intended strictly for in-vitro laboratory research and analytical purposes only. It is not approved for human consumption, diagnostic, or therapeutic use.
